Heart Failure Reviews

Papers
(The TQCC of Heart Failure Reviews is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome46
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program44
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction42
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making41
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis32
Right ventricular failure: a comorbidity or a clinical emergency?31
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Can mechanical circulatory support be an effective treatment for HFpEF patients?28
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction27
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris25
The role of TAVR in patients with heart failure: do we have the responses to all questions?25
Correction to: Is it time to revisit ICD indications?25
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?24
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition24
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution22
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review22
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?21
Clinical management of amyloid cardiomyopathy21
Filamin C in cardiomyopathy: from physiological roles to DNA variants20
Resistance training in heart failure patients: a systematic review and meta-analysis19
Speckle tracking echocardiography in heart failure development and progression in patients with apneas19
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers18
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease17
Advanced airway management and respiratory care in decompensated pulmonary hypertension17
0.31334900856018